Medline vs Xtant Medical Holdings
Medline (MDLN) and Xtant Medical Holdings (XTNT) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $48.7B
- Last close
- $37.04
- 12 months
- —
- Market value
- $29.5M
- Last close
- $0.21
- 12 months
- −67.6%
At a glance
- The biggest part of Medline's revenue is Supply Chain Solutions (52%); at Xtant Medical Holdings it is Orthobiologics (54%).
- By market value, Medline ($48.7B) is about 1653 times Xtant Medical Holdings ($29M).
- In their last fiscal years Medline kept 4.1% of revenue as net income and Xtant Medical Holdings 3.7%.
- In the last 90 days insiders reported 0 open-market purchases at Medline and 0 at Xtant Medical Holdings; members of Congress disclosed 0 trades in Medline and 0 in Xtant Medical Holdings.
- Next results: Medline Feb 23, 2027, Xtant Medical Holdings not announced.
How each one makes money: Medline revenue · Xtant Medical Holdings revenue
Share prices on one chart
Medline and Xtant Medical Holdings, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Medline MDLNNASDAQ · Surgical & Medical Instruments & Apparatus | Xtant Medical Holdings XTNTNYSE · Surgical & Medical Instruments & Apparatus | |
|---|---|---|
| Size and profitability | ||
| Market value | $48.7B | $29.5M |
| Revenue, last fiscal year | $28.4B | $134M |
| Net income, last fiscal year | $1.16B | $4.97M |
| Net marginNet income as a share of revenue | 4.1% | 3.7% |
| Free cash flow | ||
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Medline different from Xtant Medical Holdings?
Medline (MDLN) is in Surgical & Medical Instruments & Apparatus on NASDAQ, with $28.4B of revenue in its last fiscal year and a net margin of 4.1%. Xtant Medical Holdings (XTNT) is in Surgical & Medical Instruments & Apparatus on NYSE, with $134M of revenue in its last fiscal year and a net margin of 3.7%. The biggest part of Medline's revenue is Supply Chain Solutions (52%); at Xtant Medical Holdings it is Orthobiologics (54%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Medline and Xtant Medical Holdings compare in size?
Medline has the larger market value: Medline $48.7B and Xtant Medical Holdings $29.5M, at the last close.
Whose share price rose more over the last 12 months, MDLN or XTNT?
A 12-month price change is not available for both companies.
Which has had more insider buying, Medline or Xtant Medical Holdings?
Since 2006, Xtant Medical Holdings insiders reported 61 open-market purchases against 0 for Medline. These are counts of what was filed, not a view on either stock.
Do members of Congress trade MDLN or XTNT?
In the last 12 months, members of Congress disclosed 0 trades in Medline (MDLN) and 0 in Xtant Medical Holdings (XTNT).
When did insiders last buy MDLN and XTNT?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Medline pageXtant Medical Holdings pageRare insider trades this weekAll comparisons
https://oqro.io/compare/mdln-vs-xtnt

